KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Equity Average (2016 - 2025)

Historic Equity Average for Exact Sciences (EXAS) over the last 16 years, with Q3 2025 value amounting to $2.5 billion.

  • Exact Sciences' Equity Average fell 2236.56% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 2236.56%. This contributed to the annual value of $2.8 billion for FY2024, which is 1035.66% down from last year.
  • As of Q3 2025, Exact Sciences' Equity Average stood at $2.5 billion, which was down 2236.56% from $2.4 billion recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Equity Average registered a high of $3.6 billion during Q2 2021, and its lowest value of $2.4 billion during Q1 2025.
  • Its 5-year average for Equity Average is $3.1 billion, with a median of $3.1 billion in 2023.
  • In the last 5 years, Exact Sciences' Equity Average surged by 4969.92% in 2021 and then plummeted by 2355.5% in 2025.
  • Quarter analysis of 5 years shows Exact Sciences' Equity Average stood at $3.4 billion in 2021, then decreased by 10.13% to $3.1 billion in 2022, then grew by 1.87% to $3.1 billion in 2023, then decreased by 10.43% to $2.8 billion in 2024, then decreased by 11.44% to $2.5 billion in 2025.
  • Its Equity Average stands at $2.5 billion for Q3 2025, versus $2.4 billion for Q2 2025 and $2.4 billion for Q1 2025.